Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

CML State of the Art 2019: 2nd Generation TKIs Improve Molecular Outcomes and Are Generally Safe, Generic Imatinib Works Well, TFR is a Reality

28 views
November 18, 2019
Comments 0
Login to view comments. Click here to Login